According to a market report by Lucintel, the future of the psychotropic drug market in United States looks promising with opportunities in the hospital pharmacy, retail pharmacy, online pharmacy, and drug store markets. The psychotropic drug market in United States is expected to reach an estimated $30.9 billion by 2031, with a CAGR of 6.0% from 2025 to 2031. The major drivers for this market are the growing awareness and acceptance of mental health, mental diseases are growing more prevalent, and a growing geriatric population with high stress levels.
A more than 150-page report to understand trends, opportunity and forecast in psychotropic drug market in United States to 2031 by drug type (chlorpromazine, thioridazine, quetiapine, risperidone, clozapine, paroxetine, fluvoxam, and others), application (anti-psychotics, antidepressants, mood stabilizers, anti-anxiety, antiepileptic drugs, hypnotics, and stimulants), and end use (hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and others).
Download sample by clicking on psychotropic drug market in United States
Lucintel forecasts that, within the drug type category, chlorpromazine will remain the largest segment over the forecast period due to growing demand for chlorpromazine for the treatment of schizophrenia, anxiety, and bipolar disorder.
Within the end use category, hospital pharmacy will remain the largest segment because it provides patients with specialized care to treat mental illnesses.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Psychotropic Drug Market in Australia
Psychotropic Drug Market in Brazil
Psychotropic Drug Market in Canada
Psychotropic Drug Market in Mexico
Psychotropic Drug Market in Saudi Arabia
Psychotropic Drug Market in South Africa